Break-taking behaviour pattern of long-distance freight vehicles based on GPS trajectory data

This paper focuses on the break-taking behaviour pattern of long-distance freight vehicles, providing a new perspective on the study of behaviour patterns and simultaneously providing a reference for transport management departments and related enterprises. Based on Global Positioning System (GPS) trajectory data, we select stopping points as break-taking sites of long-distance freight vehicles and then classify the stopping points into three different classes based on the break-taking duration. We then explore the relationship of the distribution of the break-taking frequency between the three single classifications and their combinations, on the basis of the break-taking duration distribution. We find that the combination is a Gaussian distribution when each of the three individual classes is a Gaussian distribution, contrasting with the power-law distribution of the break-taking duration. Then we experimental analysis the distribution of the break-taking durations and frequencies, and find that, for the durations, the three single classifications can be fitted individually by an Exponential distribution and together by a Power-law distribution, for the frequencies, both the three single classifications and together can be fitted by a Gaussian distribution,so that can validate the above theoretical analysis. Key words: break-taking behaviour, long-distance freight vehicle, statistical analysi

Combination therapy with oral treprostinil for pulmonary arterial hypertension. A double-blind placebo-controlled clinical trial

Rationale: Oral treprostinil improves exercise capacity in patients with pulmonary arterial hypertension (PAH), but the effect on clinical outcomes was unknown. Objectives: To evaluate the effect of oral treprostinil compared with placebo on time to first adjudicated clinical worsening event in participants with PAH who recently began approved oral monotherapy. Methods: In this event-driven, double-blind study, we randomly allocated 690 participants (1:1 ratio) with PAH to receive placebo or oral treprostinil extended-release tablets three times daily. Eligible participants were using approved oral monotherapy for over 30 days before randomization and had a 6-minute-walk distance 150 m or greater. The primary endpoint was the time to first adjudicated clinical worsening event: death; hospitalization due to worsening PAH; initiation of inhaled or parenteral prostacyclin therapy; disease progression; or unsatisfactory long-term clinical response. Measurements and Main Results: Clinical worsening occurred in 26% of the oral treprostinil group compared with 36% of placebo participants (hazard ratio, 0.74; 95% confidence interval, 0.56–0.97; P = 0.028). Key measures of disease status, including functional class, Borg dyspnea score, and N-terminal pro–brain natriuretic peptide, all favored oral treprostinil treatment at Week 24 and beyond. A noninvasive risk stratification analysis demonstrated that oral treprostinil–assigned participants had a substantially higher mortality risk at baseline but achieved a lower risk profile from Study Weeks 12–60. The most common adverse events in the oral treprostinil group were headache, diarrhea, flushing, nausea, and vomiting. Conclusions: In participants with PAH, addition of oral treprostinil to approved oral monotherapy reduced the risk of clinical worsening. Clinical trial registered with www.clinicaltrials.gov (NCT01560624)

An optical fibre-based sensor for real-time monitoring of clinical linear accelerator radiotherapy delivery

A novel real-time optical fibre X-Ray dosimeter for monitoring the radiation pulses delivered from a clinical linear accelerator (Linac) is presented. The primary focus of the sensor is to measure low doses of ionising X-ray radiation in real time (limited to 0.1-ms gate time of the detector). The sensor tip material scintillates upon exposure to X-ray energy and the resultant low-level visible light signal is coupled to a polymethyl methacrylate plastic optical fibre, which is used to guide it towards a distal avalanche photodiode-based detector. The detector measures the low-level scintillating light from the sensor, thereby converting the ionizing radiation energy to a measurable signal with a time resolution of 0.1 ms. Results show that the scintillating optical fibre X-ray dosimeter is capable of capturing the individual X-Ray pulses delivered by the Linac during normal operation. Further examination of the results demonstrates that the sensor is capable of measuring dose rate and, hence, dose with a linearity (R-2 = 0.9995 - 0.9999) and in a highly repeatable manner for dose rates in the range 100 to 600 monitor units/min